Exarafenib
Exarafenib (RAF/KIN_2787) is an orally bioavailable, pan-RAF inhibitor that suppresses the MAPK signaling pathway, demonstrating antitumor efficacy. It is utilized in cancer research for investigating RAF-driven malignancies in both cellular and animal models.
Product Specifications
CAS Number
2639957-39-2
Product Name Alternative
Exarafenib, p38MAPK, p38 MAPK, RAF/KIN_2787
Field of Research
Signal Transduction
Purity
98.36% (May vary between batches)
Solubility
DMSO:50 mg/mL (95.86 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.83 mM)
Smiles
C[C@H] (CO) Nc1cc (cc (n1) N1CCOCC1) -c1cc (NC (=O) N2CC[C@@H] (CC (F) (F) F) C2) ccc1C
Molecular Formula
C26H34F3N5O3
Molecular Weight
521.58
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog